Beclomethasone Dipropionate Nasal prep

Indications

Beclomethasone Dipropionate Nasal prep is used for: Sinusitis, Hay fever, Allergic and non-allergic rhinitis, Nasal Polyps (Postsurgical Prophylaxis), Vasomotor Rhinitis

Adult Dose

Adults: The usual dosage is 1-2 inhalations in each nostril twice a day .

Child Dose

Children 12 Years of Age and Older: The usual dosage is 1-2 inhalations in each nostril twice a day . Children 6 to 12 Years of Age: Patients should be started with 1 inhalation in each nostril twice a day; patients with more severe symptoms may use 2 inhalations in each nostril. <6 years: Safety and efficacy not established

Renal Dose

Administration

Shake well before each use Before first use, prime pump by 6 actuations into air If not used for 7 days, reprime pump until fine spray appears

Contra Indications

patients with a history of hyper-sensitivity to any of the components

Precautions

Nasal discomfort, epistaxis, nasal ulceration, Candida albicans infection, nasal septal perforation, impaired wound healing. Avoid use in patients with recent nasal ulcers, nasal surgery, or nasal trauma. Development of glaucoma or posterior subcapsular cataracts. Hypersensitivity, rash, and urticaria may occur after administration of beclomethasone dipropionate Nasal Aerosol. Potential worsening of existing tuberculosis; fungal, bacterial, viral, or parasitic infections; or ocular herpes simplex. More serious or even fatal course of chickenpox or measles in susceptible patients. Use caution in patients with the above because of the potential for worsening of these infections. Hypercorticism and adrenal suppression with very high dosages or at the associated with seasonal and perennial allergic rhinitis in adults and regular dosage in susceptible individuals. If such changes occur, discontinue Nasal Aerosol slowly. Potential reduction in growth velocity in pediatric patients. Monitor growth routinely in pediatric patients receiving Nasal Aerosol. Monitor patients periodically for signs of adverse effects on the nasal mucosa. Monitor patients closely with a change in vision or with a history of increased intraocular pressure, glaucoma, and/or cataracts.

Pregnancy-Lactation

Pregnancy There are no adequate and well-controlled studies in pregnant women; this drug should be used during pregnancy only if potential benefit justifies potential risk to fetus Hypoadrenalism may occur in infants born of mothers receiving corticosteroids during pregnancy; such infants should be carefully observed Animal data Like other corticosteroids, beclomethasone dipropionate was teratogenic and embryocidal in the mouse and rabbit at a subcutaneous dose of 0.1 mg/kg in mice or 0.025 mg/kg in rabbits (approximately equal to the maximum recommended daily intranasal dose in adults on a mg/m2 basis) No teratogenicity or embryocidal effects were seen in rats when exposed to an inhalation dose of 0.1 mg/kg plus oral doses of up to 10 mg/kg per day for a combined dose of 10.1 mg/kg (approximately 240 times the maximum recommended daily intranasal dose in adults on a mg/m2 basis) Lactation It is not known whether beclomethasone dipropionate is excreted in human milk; because other corticosteroids are excreted in human milk, exercise caution when this drug is administered to a nursing woman

Interactions

Adverse Effects

Side effects of Beclomethasone Dipropionate Nasal prep : >10% Nasopharyngeal irritation (24%) 1-10% Headache (<5%),Nausea (<5%),Lightheadedness (<5%),Sneezing attacks after administration (4%),Nasal congestion (<3%),Nose bleeds (<3%),Rhinorrhea (<3%),Increased lacrimation (<3%),Epistaxis (<3%) Frequency Not Defined Nasal mucosa ulceration,Nasal septum perforation

Mechanism of Action

Beclometasone controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes, fibroblasts, reverses capillary permeability and lysosomal stabilisation at the cellular level to prevent or control inflammation.